Why is Lincoln Pharma. falling/rising?

As of 17-Nov, Lincoln Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 538.40, which reflects a rise of Rs 13.25 or 2.52%. The stock has shown positive momentum, gaining 6.58% over the last two days and outperforming its sector by 2.24% today. It opened with a significant gain of 6.25% and reached an intraday high of Rs 557.95. However, despite these gains, the stock has a year-to-date decline of 31.93% and a one-year decline of 12.96%, indicating a challenging longer-term performance. Notably, there has been a decrease in investor participation, with delivery volume falling by 25.75% against the five-day average, which may suggest caution among investors.
In the broader market context, Lincoln Pharmaceuticals has outperformed the Sensex in the short term, with a one-week return of 3.22% compared to the Sensex's 1.69%. This indicates that while the stock is currently rising, it is doing so against a backdrop of a generally positive market performance. However, the stock's longer-term performance remains concerning, as it has underperformed the benchmark over the year and year-to-date periods. The liquidity of the stock appears adequate for trading, but the falling delivery volume could signal potential challenges ahead if investor interest does not stabilize.